What is this study investigating:
This study is exploring an injectable investigational medication for the treatment of mild Alzheimer’s Disease.
Why is this study being conducted:
There is a significant need for those suffering from Alzheimer’s Disease to find a treatment that is efficacious in helping them.
- 104 weeks in duration with option for additional follow up study
- 46 doses every 1 month for 6 months and then every 2 weeks thereafter
You may qualify if:
- You are ages 50 to 90 years old
- You are currently suffering from mild Alzheimer’s disease